Skip to main content

AbbVie raises 2019 profit target as quarterly sales beat estimates

Drugmaker AbbVie Inc on Friday raised its earnings forecast for the year and beat Wall Street estimates for second-quarter revenue, as sales of its top-selling drug Humira did not fall as much as analysts had feared.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.